Exciting for OBJ holders. Well done.
By reference to phase II are they referring to phase II clinical trials or phase II of a 'strategy'?
If it is phase II clinical trials, then I wouldn't expect this to take too long,
Can be relatively small numbers and if as mentioned to do with sensitive teeth, then recruitment should be easy.
Particularly smart if phase II is being done oversees, as much more difficult to complete them here.
Further more, if the product is OTC, approval will be a breeze, and the trials will be done for 'clinical claim' reasons, which GSK would probably IMO, know if it works or not already.
Apologies if I have misunderstood anything and good luck !!!!
- Forums
- ASX - By Stock
- WFL
- gsk
gsk, page-4
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online